Press Room Archive - Bionical Emas

FEATURED

Charity of the Year 2025 – RareQoL

About Bionical Emas

Bionical Emas is a global Early Access Programs (EAP) and Clinical Trial Supply (CTS) group bringing life-changing medicines to patients around the world. Our range of services and capabilities benefit many of the world’s leading pharma and biotech companies.

Learn more

Charity of the Year 2025 - RareQoL

Becarus Publishing: Innovative approaches to real-world data collection in UK Early Access Programs

Bionical Emas sells EMAS Pharma to Kester Capital following strategic review

Kester Capital backs experienced management team in acquiring EMAS Pharma

Bionical Emas is recognized as one of the UK’s Best Workplaces in BioPharma™!

Charity of the Year 2024 – The Dream Factory

The Guardian - Partnering with patients on their rare disease journey

Women in Healthcare - PharmaTimes May 2023

The Guardian - Inviting patients as equal partners in the drug development process

Tom Watson appointed Chief Executive Officer

Women in Healthcare - PharmaTimes May 2022

Press